Can a common supplement shield dialysis Kids' hearts?
NCT ID NCT06286098
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily dose of alpha lipoic acid, an antioxidant supplement, can lower the risk of heart problems in 50 children who are on regular hemodialysis. Participants will either take the supplement or a placebo pill for a period, and researchers will monitor for cardiovascular events like stroke or angina, as well as measure blood markers of stress and blood vessel health. The goal is to see if this simple addition can improve outcomes for these young patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR COMPLICATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New Pediatrics Hospital, Faculty of Medicine, Ain Shams University
Cairo, El Weili, 11381, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dialysis patients may straighten up with In-Chair exercise
- Blood markers may foretell heart danger in diabetes patients
- Eye workouts while on dialysis: a new way to prevent falls?
- Dialysis dilemma: which access surgery is safer for seniors?
- Simple massage and relaxation may soothe dialysis cramps
- Flu's hidden danger: new study links infection to heart trouble